Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers
People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared to those who use another medication approved specifically for obesity management, a University of British Columbia study suggests.